Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Transdermal administration of herbal essential oil alleviates high-fat diet-induced obesity by regulating metabolism and gut microbiota.

Frontiers in pharmacology·2025
Same author

Effect of Individualized and Adaptive Vision Training versus 6 hours of Patching in Children with Residual Amblyopia: A Randomized Clinical Trial.

Ophthalmology and therapy·2025
Same author

The latent mechanism behind binocular advantage in reading.

Journal of vision·2025
Same author

Anterograde interference in multitask perceptual learning.

NPJ science of learning·2025
Same author

Transdermal administration of herbal essential oil alleviates high-fat diet-induced obesity by regulating metabolism and gut microbiota.

Frontiers in pharmacology·2025
Same author

Feasibility and limitations of combined treatment for lateral pelvic lymph node metastases in rectal cancer.

World journal of clinical oncology·2024

Related Experiment Videos

Sulfotanshinone Sodium Injection could decrease fibrinogen level and improve clinical outcomes in patients with

Fang-fang Yan, Yun-Fang Liu, Yan Liu

    International Journal of Cardiology
    |September 16, 2008
    PubMed
    Summary

    Sulfotanshinone Sodium Injection (SSI) significantly improved angina pectoris in unstable angina patients. SSI therapy, combined with aspirin, reduced attack frequency and may lower fibrinogen (FIB) levels.

    Related Experiment Videos

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Unstable angina pectoris (UAP) requires effective therapeutic interventions.
    • Evaluating novel treatments alongside standard care is crucial for improving patient outcomes.

    Discussion:

    • Sulfotanshinone Sodium Injection (SSI) demonstrated a significant improvement in the total effective rate for UAP patients.
    • The study observed a notable reduction in fibrinogen (FIB) levels in the SSI group compared to the control group.

    Key Insights:

    • SSI, when added to aspirin and baseline therapy, significantly attenuates angina pectoris attacks in UAP patients.
    • The therapeutic benefit of SSI may be linked to its ability to decrease FIB levels.

    Outlook:

    • Further research could explore the precise mechanisms by which SSI impacts FIB levels and angina severity.
    • Investigating long-term efficacy and safety of SSI in UAP management is warranted.